Linvoseltamab Recruiting Phase 2 Trials for Smoldering Multiple Myeloma (SMM) Treatment
Indications | Status | Purpose | Phase |
---|---|---|---|
Recruiting | Treatment | 2 |
clinicaltrials.gov Identifier | Title | Drugs |
---|---|---|
NCT05955508 | A Proof-of-Concept Trial to Study the Safety and Activity of Linvoseltamab in Participants With Smoldering Multiple Myeloma at High Risk of Developing Multiple Myeloma |